JBIO Q1 2025 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

JBIOJade Biosciences, Inc.

$491M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$4,000

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-3.04

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$78M

Total Liabilities

$2M

Stockholders' Equity

$75M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$4,000	-$28,000	+85.7%
Operating Income	-$3M	-$25M	+86.2%
Net Income	-$3M	-$23M	+89.1%